Omar; Abdelsattar M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Omar; Abdelsattar M..The latest application filed is for "method for making propenamide compound".
Company Profile
15.30.11
- Omar; Abdelsattar M. - Jeddah SA
- Omar; Abdelsattar M - Jeddah SA
Patent Activity
| Patent | Date |
|---|---|
| 3-vinylquinolines as cancer cells inhibitors Grant 11,345,692 - Ibrahim , et al. May 31, 2 | 2022-05-31 |
| Method for treating stomach cancer Grant 11,325,885 - El-Araby , et al. May 10, 2 | 2022-05-10 |
| Method for treating a patient having a colon cancer Grant 11,312,680 - El-Araby , et al. April 26, 2 | 2022-04-26 |
| Method for making propenamide compound Grant 11,312,694 - El-Araby , et al. April 26, 2 | 2022-04-26 |
| Methods for treating metabolic disorder Grant 11,298,321 - El-Say , et al. April 12, 2 | 2022-04-12 |
| Method For Making Propenamide Compound App 20220033368 - EL-ARABY; Moustafa E. ; et al. | 2022-02-03 |
| Method Of Treating Colorectal Cancer App 20220009896 - EL-ARABY; Moustafa E. ; et al. | 2022-01-13 |
| Chemotherapeutic oxazolone derivatives and pharmaceutical compositions thereof Grant 11,220,485 - El-Araby , et al. January 11, 2 | 2022-01-11 |
| Method for making anti-cancer compounds Grant 11,214,537 - El-Araby , et al. January 4, 2 | 2022-01-04 |
| Method of treating colorectal cancer Grant 11,214,556 - El-Araby , et al. January 4, 2 | 2022-01-04 |
| Method For Treating A Patient Having A Colon Cancer App 20210395187 - EL-ARABY; Moustafa E. ; et al. | 2021-12-23 |
| Method For Treating Stomach Cancer App 20210380526 - EL-ARABY; Moustafa E. ; et al. | 2021-12-09 |
| Method of extracting phospholipids from fish roe Grant 11,186,597 - Khedr , et al. November 30, 2 | 2021-11-30 |
| Anticancer compounds, pharmaceutical compositions thereof, and a method of treating cancer Grant 11,180,458 - El-Araby , et al. November 23, 2 | 2021-11-23 |
| Anti-cancer compounds having oxazolone derivation Grant 11,174,233 - El-Araby , et al. November 16, 2 | 2021-11-16 |
| Method For Making Anti-cancer Compounds App 20210340097 - EL-ARABY; Moustafa E. ; et al. | 2021-11-04 |
| Chemotherapeutic Oxazolone Derivatives And Pharmaceutical Compositions Thereof App 20210340110 - EL-ARABY; Moustafa E. ; et al. | 2021-11-04 |
| Bis-propenamide compounds and methods of treating cancer Grant 11,155,528 - El-Araby , et al. October 26, 2 | 2021-10-26 |
| Drug loaded flexible chitoplexes nanoparticles Grant 11,141,383 - Ahmed , et al. October 12, 2 | 2021-10-12 |
| Pharmaceutical composition for treating cancer Grant 11,142,493 - El-Araby , et al. October 12, 2 | 2021-10-12 |
| Method for treating a patient having cancer Grant 11,136,288 - El-Araby , et al. October 5, 2 | 2021-10-05 |
| Method For Treating A Patient Having Cancer App 20210188765 - EL-ARABY; Moustafa E. ; et al. | 2021-06-24 |
| Anticancer Compounds, Pharmaceutical Compositions Thereof, And A Method Of Treating Cancer App 20210139434 - EL-ARABY; Moustafa E. ; et al. | 2021-05-13 |
| Bis-propenamide Compounds And Methods Of Treating Cancer App 20210122721 - EL-ARABY; Moustafa E. ; et al. | 2021-04-29 |
| Cytotoxic compounds, pharmaceutical compositions thereof, and methods of treating cancer Grant 10,988,439 - El-Araby , et al. April 27, 2 | 2021-04-27 |
| Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabetics Grant 10,894,794 - Omar , et al. January 19, 2 | 2021-01-19 |
| Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compounds Grant 10,888,566 - El-Araby , et al. January 12, 2 | 2021-01-12 |
| 3-vinylquinolines as cancer cells inhibitors Grant 10,882,852 - Ibrahim , et al. January 5, 2 | 2021-01-05 |
| Amide Group-containing Compounds And Use For Cancer Treatment App 20200385337 - El-Araby; Moustafa E. ; et al. | 2020-12-10 |
| Cytotoxic Compounds, Pharmaceutical Compositions Thereof, And Methods Of Treating Cancer App 20200385336 - El-Araby; Moustafa E. ; et al. | 2020-12-10 |
| Pharmaceutical composition and method of treating cancer Grant 10,844,022 - El-Araby , et al. November 24, 2 | 2020-11-24 |
| Amide group-containing compounds and use for cancer treatment Grant 10,844,007 - El-Araby , et al. November 24, 2 | 2020-11-24 |
| Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compounds Grant 10,842,795 - El-Araby , et al. November 24, 2 | 2020-11-24 |
| Pharmaceutical composition with cytotoxic activity on colorectal cancer cells Grant 10,836,736 - El-Araby , et al. November 17, 2 | 2020-11-17 |
| In situ gelling formulation for reduced initial drug burst Grant 10,813,882 - Ahmed , et al. October 27, 2 | 2020-10-27 |
| Liquisolid tablet containing combined dose of tadalafil and dapoxetine Grant 10,744,137 - El-Say , et al. A | 2020-08-18 |
| Mucoadhesive buccal film having a dual release carrier system Grant 10,709,662 - Ahmed , et al. | 2020-07-14 |
| Antidiabetic compounds Grant 10,683,267 - Omar , et al. | 2020-06-16 |
| Pullulan based vinpocetine tablets, lyoplant-tabs, as a buccal solid dosage form Grant 10,668,020 - Omar , et al. | 2020-06-02 |
| Antidiabetic compounds Grant 10,654,800 - Omar , et al. | 2020-05-19 |
| Polymeric nanoparticulate formulation to enhance the oral bioavailability of dapoxetine Grant 10,653,634 - El-Say , et al. | 2020-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 